We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
-21.34%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$2.25B
AUM Growth
-$778M
Cap. Flow
-$28.8M
Cap. Flow %
-1.28%
Top 10 Hldgs %
44.93%
Holding
223
New
5
Increased
26
Reduced
99
Closed
34

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$16.6M
2
WAB icon
Wabtec
WAB
+$14.3M
3
BUD icon
AB InBev
BUD
+$11.4M
4
USB icon
US Bancorp
USB
+$7.91M
5
BAX icon
Baxter International
BAX
+$6.59M

Sector Composition

Rank Sector Weight
1 Financials 33.6%
2 Healthcare 17.71%
3 Technology 15.08%
4 Communication Services 9.83%
5 Industrials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$171M 7.62%
1,086,191
-9,969
-0.9% -$1.64M
BX icon
2
Blackstone
BX
$104B
$140M 6.22%
3,068,578
-106,823
-3% -$5.91M
APO icon
3
Apollo Global Management
APO
$69B
$115M 5.12%
3,435,787
+10,265
+0.3% +$441K
ESGR
4
DELISTED
Enstar Group
ESGR
$112M 4.98%
704,416
-6,088
-0.9% -$1.12M
ROP icon
5
Roper Technologies
ROP
$40.4B
$101M 4.48%
322,809
-14,728
-4% -$5.22M
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.11T
$80M 3.56%
1,375,900
-12,860
-0.9% -$873K
CACC icon
7
Credit Acceptance
CACC
$5.82B
$78M 3.47%
304,915
+1,536
+0.5% +$620K
ABT icon
8
Abbott
ABT
$188B
$77.9M 3.46%
986,929
-26,124
-3% -$2.18M
LUMN icon
9
Lumen
LUMN
$6.43B
$68M 3.02%
7,188,702
-170,856
-2% -$2.14M
LH icon
10
Labcorp
LH
$25.2B
$67.5M 3%
622,088
+37,903
+6% +$5.46M
WAT icon
11
Waters Corp
WAT
$37.3B
$62.7M 2.79%
344,343
-23,184
-6% -$4.89M
JPM icon
12
JPMorgan Chase
JPM
$916B
$54.4M 2.42%
604,772
+3,451
+0.6% +$419K
SHW icon
13
Sherwin-Williams
SHW
$84.8B
$46.3M 2.06%
302,229
-3,969
-1% -$716K
MKL icon
14
Markel Group
MKL
$25.2B
$45.9M 2.04%
49,459
-2,230
-4% -$2.55M
AWI icon
15
Armstrong World Industries
AWI
$7.37B
$45.5M 2.02%
572,414
-18,934
-3% -$1.82M
JNJ icon
16
Johnson & Johnson
JNJ
$640B
$44.5M 1.98%
339,588
-8,424
-2% -$1.2M
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$4.12T
$43.4M 1.93%
746,240
-5,460
-0.7% -$370K
BRK.B icon
18
Berkshire Hathaway Class B
BRK.B
$1.1T
$40.2M 1.79%
219,857
-3,829
-2% -$814K
EPD icon
19
Enterprise Products Partners
EPD
$83.7B
$39.9M 1.77%
2,786,916
+492,328
+21% +$11.4M
SCHW
20
Charles Schwab
SCHW
$182B
$39M 1.74%
1,160,494
+194,368
+20% +$8.16M
TEVA icon
21
Teva Pharmaceuticals
TEVA
$40.4B
$35.6M 1.58%
3,961,183
+1,007,043
+34% +$10.3M
QCOM icon
22
Qualcomm
QCOM
$164B
$35.3M 1.57%
521,696
-18,427
-3% -$1.51M
JEF icon
23
Jefferies Financial Group
JEF
$12.7B
$34.8M 1.55%
2,661,045
-184,544
-6% -$3.52M
BAX icon
24
Baxter International
BAX
$12.8B
$31.5M 1.4%
387,455
-76,325
-16% -$6.59M
WMS icon
25
Advanced Drainage Systems
WMS
$10.6B
$31.3M 1.39%
1,061,986
+98,709
+10% +$3.99M

Similar funds

Beck Mack & Oliver's Q1 2020 Portfolio in Review

As of Q1 2020, Beck Mack & Oliver held 223 positions worth $2.25B, down 26% from $3.03B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Beck Mack & Oliver's Q1 2020 filing shows 5 new, 26 increased, 99 reduced and 34 closed positions. Its largest new stake was Hilton Worldwide: 8,220 shares worth $561K. The largest sale was Gilead Sciences, an estimated $16.6M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, down from 35% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q1 2020 buy was Hilton Worldwide: 8,220 shares worth $561K.
  • Beck Mack & Oliver added most to RadNet in Q1 2020, an estimated $15.7M increase.
  • Beck Mack & Oliver's biggest Q1 2020 reduction was Gilead Sciences, cutting an estimated $16.6M.
  • Beck Mack & Oliver fully exited Carlisle Companies in Q1 2020, selling an estimated $1.08M.
  • Beck Mack & Oliver's ten largest holdings make up 45% of its $2.25B portfolio in Q1 2020.
  • Beck Mack & Oliver opened 5 new positions and closed 34 in Q1 2020.
  • Beck Mack & Oliver's portfolio value fell 26% quarter-over-quarter to $2.25B.

Based on Beck Mack & Oliver's 13F filing for Q1 2020, filed 5 May 2020.